Samsung Medical Center
Samsung Medical Center is a Seoul-based tertiary academic hospital and Samsung Group affiliate delivering comprehensive inpatient, outpatient, and specialty care across cancer, cardiovascular, and proton therapy centers. It combines advanced smart-hospital infrastructure with AI-driven diagnostic, surgical, and drug-discovery research collaborations.
- Company typePrivate
- Founded1994
- HeadquartersYeoksamdong, South Korea
- Headcount501–1,000
- GTM typeB2C
- OfferingServices
What Samsung Medical Center does
Samsung Medical Center (삼성서울병원), founded in 1994 in Seoul's Gangnam district, is a tertiary care academic medical center operating within the Samsung Group conglomerate and affiliated with Sungkyunkwan University School of Medicine. It delivers comprehensive inpatient and outpatient services across more than 40 departments and runs dedicated specialized hospitals for cancer, cardiovascular and cerebrovascular care, health screening, and proton therapy, supported by a network of wholly-owned affiliates including Kangbuk Samsung Hospital and Samsung Changwon Hospital. The institution ranks #1 in Asia-Pacific for oncology, pulmonology, and gastroenterology in the 2026 Newsweek/Statista rankings and has achieved HIMSS INFRAM Stage 7 plus the world's first HIMSS CCMM Stage 6 certification, signaling a mature smart-hospital infrastructure.
The technology backbone centers on AI-ready clinical systems, advanced medical data platforms, and a pipeline of AI-driven diagnostic and therapeutic capabilities. Notable proprietary initiatives include the AURORA Lab for AI surgical robot development (lead role in a Ministry of Health and Welfare consortium with ~10 billion won in funding through 2030), an AI Star Fellow consortium with KAIST for disease-reasoning models, a Raman-spectroscopy CSF diagnostic platform validated at 90.8% accuracy, and a wireless ultrasound-driven electroceutical device for non-pharmacological pain relief. Research output includes a Nature whole-genome breast cancer study (1,364 genomes) and a Sleep-journal publication analyzing wearable data from 274,128 U.S. adults, indicating access to large-scale clinical and consumer health datasets.
Commercially, Samsung Medical Center generates revenue primarily through South Korea's National Health Insurance plus private-pay services for non-covered treatments, with additional streams from international medical tourism, health-screening programs, and clinical research services (including A-CRO drug development support). Distribution is anchored to its single Seoul campus operating 365 days with 24-hour emergency services, supplemented by referral partnerships, academic symposia, and digital patient engagement channels. The hospital does not publicly disclose pricing or revenue figures.
Samsung Medical Center firmographics
Firmographics- Name
- Samsung Medical Center
- Legal name
- Samsung Medical Center (삼성서울병원)
- Website
- https://samsunghospital.com
- Company type
- Private
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Samsung Medical Center is a Seoul-based tertiary academic hospital and Samsung Group affiliate delivering comprehensive inpatient, outpatient, and specialty care across cancer, cardiovascular, and proton therapy centers. It combines advanced smart-hospital infrastructure with AI-driven diagnostic, surgical, and drug-discovery research collaborations.
- Ownership category
- akta.pro rank
Samsung Medical Center industry classification
Industry- Product category
- Tertiary Hospital and Specialty Healthcare Services
- NAICS
- General Medical and Surgical Hospitals (62211), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), General Medical and Surgical Hospitals (622110)
- SIC
- Services-Health Services (8000), Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062)
- akta.pro primary industry
- Oncology & Cancer Specialty Hospitals (HLAFAHAC)
Keywords
Where Samsung Medical Center is headquartered
LocationHeadquarters
- HQ city
- Yeoksamdong
- HQ country
- South Korea
- HQ region
- Asia
Offices1 record
Markets served
Samsung Medical Center business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Distribution channels2 records
Marketing channels3 records
Samsung Medical Center product offering
Product offeringCore offering
Samsung Medical Center operates a comprehensive tertiary hospital providing inpatient and outpatient medical care across all major specialties, anchored by specialized hospitals for cancer, cardiovascular and cerebrovascular disease, proton therapy, and a preventive health screening center. It also delivers organ transplantation, emergency, intensive care, palliative/home care, and clinical research services, while serving as a research platform for AI-driven diagnostics, surgical robotics, and precision oncology through affiliations with Samsung Group entities and Korean academic partners.
Product overview
Samsung Medical Center (Samsung Seoul Hospital) is a comprehensive medical center offering a multi-specialty hospital structure with specialized hospitals and centers. The portfolio includes the general Samsung Seoul Hospital with all core medical departments, the specialized Cancer Hospital with 14+ cancer-specific treatment centers, the Cardiovascular and Cerebrovascular Hospital, the Health Medicine Center for preventive care, and the Proton Therapy Center for advanced radiation treatment. Additional services include specialized centers for brain/nerve, transplant, intensive care, emergency, and palliative care, plus the Future Medical Research Institute for innovation and the Clinical Research Center for trials. The institution is part of the Samsung medical network including Kangbuk Samsung Hospital and Samsung Changwon Hospital.
Differentiator
Problem solved
Functional benefit
Brands
- Cancer Hospital (암병원): Specialized cancer treatment center with multiple cancer-specific centers including liver, brain tumor, colorectal, head and neck, gynecologic, urological, gastric, breast, pancreatic/biliary, rare cancer, lung/esophageal, and blood cancer centers
- Cardiovascular Hospital (심장뇌혈관병원)
- Health Promotion Center (건강의학센터)
- Proton Therapy Center (양성자치료센터)
- Future Medical Research Institute (미래의학연구원)
- AURORA Lab
Products and services
- Samsung Seoul Hospital (삼성서울병원) Comprehensive tertiary hospital providing general and specialized inpatient and outpatient medical care across all major departments, including internal medicine, surgery, and pediatrics, with subspecialty centers for cancer, cardiovascular, neurological, and other complex conditions.
- Cancer Hospital (암병원) Specialized cancer treatment center with 14+ cancer-specific centers covering liver, brain tumor, colorectal, head and neck, gynecologic, urological, gastric, breast, pancreatic/biliary, rare cancer, lung/esophageal, and blood cancers, plus radiation oncology and proton therapy.
- Cardiovascular and Cerebrovascular Hospital (심장뇌혈관병원) Specialized hospital for heart and cerebrovascular diseases featuring a cardiac center, arrhythmia center, stroke center, vascular center, preventive rehabilitation center, and imaging center.
- Health Medicine Center (건강의학센터) Preventive health examination and wellness center offering comprehensive multi-system checkup programs and健康管理 (health management) services for individuals and corporate clients.
- Proton Therapy Center (양성자치료센터) Advanced proton beam therapy facility providing precise radiation treatment for cancer patients.
- Future Medical Research Institute (미래의학연구원) Research institute dedicated to pioneering medical research and innovation, supporting advanced medical science development at the hospital.
- Specialized Centers (Brain/Nerve, ICU, Emergency, Palliative, Home Care) Targeted specialty service lines including the Brain and Nerve Center, Intensive Care Unit, Home Care Center, Emergency Center, and Palliative Care Center.
- Organ Transplant Center (장기이식센터) Comprehensive organ transplantation services including heart transplantation and other solid organ transplant procedures.
- Clinical Research Center (임상의학연구소) Research center conducting clinical trials and supporting medical research with A-CRO (academic contract research organization) services for drug development.
- SMC Partner Center (SMC파트너즈센터) Referral partner network center facilitating medical referrals and partnerships with other healthcare institutions.
Companies that use Samsung Medical Center
Customer profileNamed customers3 records
Segments2 records
Ideal customer profiles3 records
Samsung Medical Center technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Samsung Medical Center partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered major and core.
- Sungshin Women's University, Samsung Electronics, Harvard Medical SchoolmajorJoint research team published study in journal 'Sleep' analyzing sleep data from 274,128 U.S. adults wearing Samsung Galaxy Watches. Study found individual sleep needs vary significantly (6.5 to 9 hours), challenging the widely held recommendation that everyone needs 7-8 hours of sleep.
- Nine-institution consortium for wearable exoskeletonmajorNine-institution consortium including DGIST, KAIST, Seoul National University Hospital, Gangnam Severance Hospital, Samsung Medical Center, and Pusan National University Hospital. Severance Hospital leads a seven-year government-funded project to develop a wearable exoskeleton using AI to read brain signals from quadriplegic patients, with government funding of 20.25 billion won ($13 million) and total investment reaching about 30 billion won ($19 million).
- Samsung BioepiscoreSamsung Bioepis and Samsung Medical Center signed a joint research agreement to collaborate on AI-driven drug research, establishing a consultative body and research advisory committee to carry out collaborative projects through 2030. Samsung Bioepis plans to leverage SMC's extensive medical data to develop AI-powered treatment technologies, build a platform for identifying novel drug targets, and support development of innovative therapeutics including antibody-drug conjugates.
- Ministry of Health and WelfarecoreSamsung Medical Center selected as lead organization for Ministry of Health and Welfare's AI-based surgical robot innovation project, receiving approximately 10 billion won in government funding over five years to build a development and validation framework for AI surgical robots. Collaboration with Rainbow Robotics, E-ROBE, Roen Surgical, Samsung Advanced Institute for Health Sciences and Technology, DGIST, and Tomorrow Robotics to establish the AURORA lab.
- Kyung Hee University Hospital at GangdongmajorResearchers from Kyung Hee University Hospital at Gangdong and Samsung Medical Center studied over 1.3 million adults aged 40 and older without dementia from 2013 to 2024, finding that people with insulin-dependent diabetes face significantly higher dementia risk than those without diabetes.
- Sungkyunkwan UniversitymajorResearch team at Sungkyunkwan University in Seoul developed world's first AI-based optical diagnostic platform capable of distinguishing between nasal secretion and cerebrospinal fluid using Raman spectroscopy with AI-based machine learning. Platform achieved 90.8% diagnostic accuracy in identifying CSF leakage in clinical samples from Samsung Medical Center.
- Yonsei UniversitymajorJoint research team from Yonsei University and Samsung Medical Center developed a wireless electroceutical device that uses ultrasound to generate triboelectricity in a biodegradable polymer, blocking nerve signals for pain relief without drugs, electrodes, or batteries. Preclinical trials demonstrated significant pain reduction with rapid nerve function recovery.
- Seoul St. Mary's Hospital and Inocras Inc.coreResearch consortium led by Samsung Medical Center, Seoul St. Mary's Hospital, and Inocras Inc. published comprehensive whole-genome breast cancer study in Nature, analyzing 1,364 genomes and clinical data. Study identified biomarkers linked to treatment responses and prognosis, supporting precision oncology advancements.
- Samsung ElectronicscoreSamsung Medical Center collaborated with Samsung Electronics on Galaxy Watch health sensors including enhanced ECG for ectopic beat detection, PPG for vascular load monitoring, and personalized Bedtime Guidance clinically validated at the medical center.
- KAIST (Korea Advanced Institute of Science and Technology)coreKAIST research team launched the 'AI Star Fellow Project' in collaboration with Samsung Medical Center, Naver Cloud, and HITS to develop AI models for disease reasoning, diagnosis, and new drug discovery, backed by 11.5 billion KRW in government funding through December 2030. The consortium plans to commercialize clinical diagnostic AI, AI-based molecular target exploration for drug development, and an expandable AI reasoning platform.
Scale indicators5 records
Samsung Medical Center competitors and assessment
Company assessmentDirect peers
- Korea University Anam Hospital: Leading Korean academic medical center affiliated with Korea University, providing comparable tertiary care and specialty services. Direct competitor in the Seoul metropolitan market for complex patient care and clinical research.
- Asan Medical Center: One of the largest hospitals in Korea by bed capacity, also ranked among the top Asia-Pacific hospitals by Newsweek. Direct competitor for cancer care, organ transplantation, and cardiovascular services in the Seoul metropolitan area.
- Seoul St. Mary's Hospital: Catholic University of Korea's flagship hospital, comparable academic medical center providing tertiary care and cancer services. Direct research partner with SMC on the Nature whole-genome breast cancer study and competes for similar patient demographics.
- Seoul National University Hospital: Korea's flagship national university hospital and academic medical center, providing comparable tertiary and quaternary care across all major specialties. Direct competitor for top physician talent, research funding, and complex patient referrals within the Korean market.
- Severance Hospital: Yonsei University Health System's flagship hospital and a leading Korean academic medical center. Direct competitor in oncology, specialty care, and medical research; leads the wearable exoskeleton consortium that SMC participates in.
- Bundang Seoul National University Hospital: Seoul National University's secondary hospital in Bundang, providing similar tertiary care services with strong research capabilities. Competes with SMC for Gyeonggi province and greater Seoul patient populations.
Regional players
- Bumrungrad International Hospital: Leading medical tourism hospital in Bangkok, Thailand, and a major Asia-Pacific competitor for international patients seeking specialty care. Comparable in brand positioning for regional medical tourism but operates primarily in Southeast Asia.
- Singapore General Hospital: Singapore's largest tertiary hospital and academic medical center, comparable in scale and specialty services. Regional Asia-Pacific peer competing for medical tourism and clinical research partnerships, though primarily serving the Singapore market.
Broad incumbents
- Kangbuk Samsung Hospital: Sister hospital within the Samsung medical network (wholly owned), serving the northern Seoul area. Provides general hospital services as part of the broader Samsung Group healthcare ecosystem alongside the flagship Samsung Medical Center.
- Samsung Changwon Hospital: Sister hospital within the Samsung medical network (wholly owned), extending SMC's brand into the southeastern Korean market. Part of the broader Samsung hospital ecosystem but operates as a regional general hospital rather than a quaternary specialty center.
Market position
Strengths5 records
Weaknesses5 records
Key risks6 records
Key highlights7 records
Customer concentration
Samsung Medical Center social profiles
Digital presenceSamsung Medical Center financial estimates
Financial estimateRevenue estimate
Valuation estimate
Samsung Medical Center leadership team
Management profileNumber of profiles
Profiles2 records
Samsung Medical Center subsidiaries and ownership
Company hierarchySubsidiaries3 records
Samsung Medical Center funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Samsung Medical Center M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Samsung Medical Center
What does Samsung Medical Center do?
Samsung Medical Center operates a comprehensive tertiary hospital providing inpatient and outpatient medical care across all major specialties, anchored by specialized hospitals for cancer, cardiovascular and cerebrovascular disease, proton therapy, and a preventive health screening center. It also delivers organ transplantation, emergency, intensive care, palliative/home care, and clinical research services, while serving as a research platform for AI-driven diagnostics, surgical robotics, and precision oncology through affiliations with Samsung Group entities and Korean academic partners.
Is Samsung Medical Center a public or private company?
Samsung Medical Center is a private company. It is classified as corporate owned and is currently operating.
When was Samsung Medical Center founded?
Samsung Medical Center was founded in 1994. It employs 501 to 1,000 people.
Where is Samsung Medical Center based?
Samsung Medical Center is headquartered in Yeoksamdong, South Korea, in the Asia region.
Who are Samsung Medical Center's main competitors?
Direct peers on record are Korea University Anam Hospital, Asan Medical Center, Seoul St. Mary's Hospital, Seoul National University Hospital, Severance Hospital and Bundang Seoul National University Hospital. Regional players are Bumrungrad International Hospital and Singapore General Hospital. Broad incumbents are Kangbuk Samsung Hospital and Samsung Changwon Hospital.
Does Samsung Medical Center have an API?
No public API is recorded for Samsung Medical Center.
What industry is Samsung Medical Center in?
Samsung Medical Center's product category is Tertiary Hospital and Specialty Healthcare Services. Its primary akta.pro industry code is HLAFAHAC, Oncology & Cancer Specialty Hospitals. Its NAICS code is 62211 and its SIC code is 8000.